28
Participants
Start Date
August 31, 2020
Primary Completion Date
December 4, 2025
Study Completion Date
December 10, 2025
MAS-1 adjuvanted Insulin B-chain
MER3101 (MAS-1 adjuvanted insulin B chain (IBC)), is a white, free-flowing 30:70 (w/w) water-in-oil (W/O) emulsion. MER3101 contains in the aqueous (disperse) phase 33, 109, or 327 µg per 0.25 mL dose of IBC (Drug Substance) and the oil (continuous) phase is comprised of MAS-1 oil vehicle.
RECRUITING
University of Colorado, Denver, Aurora
Collaborators (1)
The Leona M. and Harry B. Helmsley Charitable Trust
OTHER
Nova Immunotherapeutics Limited
INDUSTRY
University of Colorado, Denver
OTHER